{
    "clinical_study": {
        "@rank": "106075", 
        "arm_group": [
            {
                "arm_group_label": "Chronic Hepatitis B", 
                "description": "Diagnosis of Hepatitis B related liver disease in a pre-advanced stage"
            }, 
            {
                "arm_group_label": "End stage liver disease", 
                "description": "Diagnosis of advanced liver disease related to Hepatitis B"
            }
        ], 
        "biospec_descr": {
            "textblock": "serum whole blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "In this project proposal, the investigators will investigate the genetic alterations of\n      Hepatitis B Virus (HBV) strains circulating in Belgian patients who developed end stage\n      liver disease. Additionally, the investigators will compare and link these data sets with\n      three genetic factors involved in immune system response."
        }, 
        "brief_title": "Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hepatitis B", 
            "Hepatitis B, Chronic", 
            "End Stage Liver Disease", 
            "Carcinoma, Hepatocellular"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Hepatitis", 
                "Hepatitis A", 
                "Hepatitis B", 
                "Liver Diseases", 
                "Hepatitis B, Chronic", 
                "End Stage Liver Disease", 
                "Carcinoma, Hepatocellular"
            ]
        }, 
        "detailed_description": {
            "textblock": "This project proposes to identify and characterize the genetic alterations associated with\n      intra-host evolution of HBV from a chronically infection status to an end-stage liver\n      disease status."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Study group:\n\n          -  Clinical diagnosis of advanced liver disease related to chronic Hepatitis B infection\n             (cirrhosis, hepatocellular carcinoma,..)\n\n          -  Availability of serum samples\n\n        Control group:\n\n          -  Clinical diagnosis of liver disease related to chronic Hepatitis B infection in a\n             pre-advanced stage\n\n          -  Matched demographic and geographic characteristics to study group\n\n          -  Availability of serum samples\n\n        Exclusion Criteria:\n\n          -  Liver disease caused by other hepato-tropic viruses\n\n          -  Patients with auto-immune diseases"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with liver disease related to Hepatitis B in a pre-advanced (chronic infection)\n        and advanced stage (end-stage liver diseases) treated at the Hepatology Department of\n        University Hospital of Leuven"
            }
        }, 
        "enrollment": {
            "#text": "274", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02148562", 
            "org_study_id": "S56121", 
            "secondary_id": "12G1714N"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 22, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Leuven", 
                    "country": "Belgium", 
                    "state": "Flemish Brabant", 
                    "zip": "3000"
                }, 
                "name": "University Hospitals Leuven campus Gasthuisberg"
            }
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_groups": "2", 
        "official_title": "Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity With Next-generation Sequencing: From Chronic Infection to End-stage Liver Disease and Liver Cancer", 
        "overall_official": {
            "affiliation": "UZ Leuven campus Gasthuisberg, Herestraat 49. 3000 Leuven, Belgium", 
            "last_name": "MahmoudReza Pourkarim, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Virus variants will be identified by amino acid or nucleotide variations (insertions or deletions) in different Open Readind Frames (ORFs) of the HBV genome by using next-generation sequencing.\nComparison of virus variants within one patient Comparison of virus variants between patients with end stage liver disease and patients with a chronic Hepatitis B infection.\nDetermination of the viral load by quantitative Polymerase Chain Reaction (PCR).", 
            "measure": "genetic variants of Hepatitis B", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02148562"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universitaire Ziekenhuizen Leuven", 
            "investigator_full_name": "MahmoudReza Pourkarim", 
            "investigator_title": "PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Amplification of HLA-A, HLA-B, HLA-C class I and HLA class II using PCR methods and next-generation sequencing\nAmplification of KIR genes: 2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DS1 and 1D, 2DL1 2DL2, 2DL3, 2DL5 and 3DL1 using PCR methods and next-generation sequencing\nAmplification of SNPs in TNF alfa, TGF beta1 and IFN-R using PCR methods and next-generation sequencing", 
            "measure": "genetic variation in host-specific immune markers", 
            "safety_issue": "No", 
            "time_frame": "at day of enrollment"
        }, 
        "source": "Universitaire Ziekenhuizen Leuven", 
        "sponsors": {
            "collaborator": {
                "agency": "Fund for Scientific Research, Flanders, Belgium", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Universitaire Ziekenhuizen Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}